Home » News » Awards & Advancement » LabCorp announces new Covance leadership

LabCorp announces new Covance leadership

Thursday, July 30, 2015

Deborah Keller will succeed Joseph Herring as chief executive officer of Covance Drug Development. Herring will retire July 31 after more than a decade as chief executive officer.

Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance and marketing. Most recently, she was executive vice president, Covance and group president, R&D Laboratories, where she led the combined central laboratory and early development laboratory organizations of more than 6,000 employees at 18 facilities across the globe.

As chief executive officer of Covance, Keller also will be a member of the Laboratory Corporation of America Holdings (LabCorp) executive committee and will report to David P. King, chairman and chief executive officer of LabCorp.

 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!